Content area
Full Text
I have known Shelly since 1980 when we meet at a professional meeting. Now, he is the head of Infectious Disease at Baylor College of Medicine in Houston, where he has helped pioneer some of the most important research on methicillin-resistant Staphylococcus aureus . He also sits on the pediatric infectious diseases sub-board of the American Board of Pediatrics and is on the US Food and Drug Administration's Advisory Committee for Anti-infective Drugs. And, like me, he's a chocoholic, but he likes milk chocolate nonpareils, which are bumpy, not crunchy, and that's just weird.
Stanford T. Shulman, MD
Dr. Shulman:
How did you get involved with methicillin-resistant Staphylococcus aureus (MRSA) research?
Dr. Kaplan:
We got interested in MRSA because in the late 1990s we were suddenly starting to see a number of patients presenting with serious infections. We went about studying it in 2000. We didn't really realize how big of an issue this was going to be -- it's essentially now the most common organism that causes a community skin and soft tissue infection in the Houston area, where we are, as well as in Dallas and in many other...